CAS#2171019 - 55 - 7|2- (4- (2- (7,8-dimetil- [1,2,4] triazolo [1,5-A] piridin-6-il) -3- (propan-2-il) -1h-inol-5-il) piperidin-1-il) asetamid

Non pwodwi	2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-(propan-2-yl)-1H-indol-5-yl)piperidin-1-yl)acetamide	Fòmil estrikti	​
CAS No.	2171019-55-7	Pwa molekilè	444.57
Aparisyon	Solid	Fòmil	C26H32N6O
Asay	98%	Pakèt	5kg; 1kg

 

Aplikasyon

 

• Afimetoran (BMS - 986256) se yon antagonist oralman, selektif, ak trè byodisponib TLR7/8. Afimetoran (BMS-986256) ka anpeche TLR7/8 aktivasyon nan chemen an NF-κB ak ranvèse TLR7 medyatè rezistans nan apoptoz esteroyid pwovoke nan selil plasma tankou selil dendritik (PDCs). Afimetoran (BMS-986256) ka itilize pou rechèch sou enflamasyon ak maladi auto-immunes (sistemik lupus eritematos) [1] [2].

 

Anbake

 

 

Baj popilè: CAS#2171019 - 55 - 7|2 - (4 - (2- (7,8-dimetil- [1,2,4] Triazolo [1,5-A] piridin-6-il) -3- (propan-2-il) -1H-Enol-5-il) Piperidin-1-AL), Acetam-1h-inol-5-il) Piperidin-1-AL), Acetam-1-inol-5-il) Piperidin-1-AL), Acetam-1-inol-5-il) Piperidin-1-AL), Acetam-1-inol-5-il) PiperIdin-1-AL), Acetam-1h-inol-5-yl) Piperidin-1-AL), Acetam-1h-inol-5-yl) Piperidin-1-AL), ACETAM -1H-INDOL-5-il), 2- (4- (2- (7,8-dimetil- [1,2,4] triazolo [1,5-A] piridin-6-il) -3- (propan-2-il) -1H-indol-5-il) Piperidin-1-il) manifaktirè asetamid, founisè, faktori